Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatment
L. Roccatagliata, M. Rocca, P. Valsasina, L. Bonzano, M. Sormani, R. Saccardi, et al. (2007). The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. MULTIPLE SCLEROSIS, 13, 1068-1070.
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study
A LugaresiMembro del Collaboration Group
;
2007
Abstract
Using MRI, we measured disease activity and brain atrophy in nine multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT) for a mean follow up of 63 months. We show that AHSCT is associated to a longlasting suppression of inflammation and to a marked decrease of the rate of brain atrophy after the second year following treatmentFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
